You are here:

valsartan (Diovan)

Advice

Following an abbreviated submission:

valsartan (Diovan®) is accepted for restricted use within NHS Scotland.

Indication under review: treatment of hypertension in children and adolescents 6 to 18 years of age.

SMC restriction: use should be on the recommendation of a paediatric specialist consultant.
The licence for the adult indication pre-dates SMC.

Drug Details

Drug Name: valsartan (Diovan)
SMC Drug ID: 649/10
Manufacturer: Novartis Pharmaceuticals UK Ltd
Indication: Treatment of hypertension in children and adolescents 6 to 18
BNF Category:
Sub Category: 2.5 Hypertension and heart failure
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 17 January 2011

Back